France · Delayed Price · Currency is EUR Arkema Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 delivered stable volumes and strong Specialty Materials growth, offset by currency headwinds and weak U.S./Europe demand. EBITDA rose 14% sequentially but fell year-on-year; price increases and major projects are set to support Q2 and full-year guidance.
Fiscal Year 2025
-
2025 saw challenging macro conditions with weak demand in Europe and the U.S., but strong growth in Asia. EBITDA fell to EUR 1.25 billion, but cash generation and cost control exceeded targets. 2026 guidance is for slight EBITDA growth at constant FX, with major projects and a new segment structure supporting future performance.
-
Q3 2025 saw sales down 8.6% year-on-year amid weak U.S. and European demand, but strong growth in Asia and targeted markets like batteries and fluorospecialties. Cost savings and disciplined capital allocation supported cash flow, with 2025 EBITDA guidance set at €1.25–1.3 billion.
-
Q2 2025 saw resilient margins and cash flow despite weak demand in Europe and the US, with Asia providing growth in high-performance polymers. 2025 EBITDA is guided at €1.3–1.4 billion, supported by cost savings and major project ramp-ups, while leverage remains stable.
-
Q1 2025 saw resilient specialty materials performance amid weak demand in Europe and the U.S., offset by strong growth in Asia and electronics. EBITDA declined 6% year-over-year to €329 million, but major projects and Dow adhesives integration are expected to drive H2 improvement.
Fiscal Year 2024
-
2024 results were resilient with stable sales, 2% EBITDA growth, and a 16.1% margin, supported by strong specialty materials and balanced global exposure. 2025 guidance targets further EBITDA growth, with major projects ramping up and a focus on cost discipline amid macro uncertainty.
-
Q3 2024 delivered 2.9% sales growth and 5.4% EBITDA increase, driven by specialty materials in Asia and the U.S., despite ongoing macroeconomic challenges. 2024 EBITDA is expected at the lower end of guidance, with major projects set to add €440 million EBITDA by 2028.
-
Q2 2024 saw 5% volume growth and 8% higher EBITDA, with all segments contributing and adhesives leading. Annual EBITDA guidance was raised to €1.53–1.63 billion, despite macro headwinds and a €15 million flooding impact in Germany. Major organic projects and M&A are set to drive future growth.